Kevin Hoffmann Email & Phone Number

Denver

• Led the development of a turnaround and growth strategy for a major regional health system, driving ~$150M in cost reductions to fund ambitious growth initiatives adding $100M+ in first-year revenue.• Managed and directed a cross-functional team of ~100 senior executives, designers, engineers, and consultants to develop and launch a new digital product offering at a leading national health system. Ran critical PMO coordinating design, development, and business integration to achieve an on-time launch, resulting in rapid adoption by ~5M users.• Spearheaded sell-side due diligence and operational disentanglement of a biopharma carveout. Streamlined the research portfolio and operations and orchestrated a roadshow to raise ~$100M in Series A funding.• Partnered with the senior leadership team of a $4B insurance company to identify and realize ~$200M in cost savings including rebidding major contracts, organizational design, and functional outsourcing and offshoring.

Denver, Colorado, United States

• Partnered with C-suite and private equity operating partners of a major physician group to achieve a profitable growth trajectory (5% revenue CAGR, +$100M EBITDA). Created a sustainable partner-equity model to attract 400+ new specialists without diluting existing investors, leading to a $2B+ valuation sale—the largest of its kind.• Led buy-side diligence of a ~$350M healthcare pharmacy asset. Valued the target using trading multiples, transaction comparables, and DCF models and identified and sized synergy opportunities worth ~$200M.• Developed a market entry strategy for a novel infusion drug with up to ~15 million potential patients and a total addressable market of $250–500 billion. Identified adoption barriers along the patient journey and designed and prioritized outreach and marketing initiatives to accelerate uptake upon regulatory approval.• Crafted a digital product strategy for a leading academic medical center by assessing ~60 highly innovative product concepts. Directed ~$50M in CAPEX and co-designed and co-developed a digital care delivery product for cancer diagnoses.• Led an interdisciplinary team to transition a 5,200-employee health system to a flexible hybrid remote work model. Enhanced employee experience and retention while attracting talent beyond geographic constraints. Redesigned physical spaces for effective hybrid work, achieving $20M in annual real estate savings, a $60M NPV, and access to a 140x larger, more diverse talent pool.

Minneapolis, Minnesota, United States

• Optimized R&D and product marketing functions for a leading MedTech company leading to ~$10M in annual cost savings for reinvestment. Established agile cross-functional teams and streamlined new product development by rationalizing SKUs and development pipeline and accelerating product launches.• Supported a health system during the COVID-19 crisis by developing financial projection models, scenario analysis, and a detailed resource planning tool. Accurately forecasted cash flow impacts which enabled significantly fewer than expected furloughs, and optimized resource and material allocation to meet surge demand on a facility level.• Includes 1 year LOA to receive my MBA at Kellogg

Munich, Germany And Minneapolis, United States

• Redesigned trade terms system for a global packaged food company that was overspending on promotions. Collaborated closely with key account managers to revise retailer contracts, identifying savings potential of over $400M in promotion spend based on data modeling for over 300k product-specific promotions. Optimized new trade terms through workshops, pilots, and development and rollout of a new pricing tool.• Formulated pricing strategy for a leading retailer perceived as expensive by customers. Defined key value items for aggressive price matching against local competitors, resulting in a sales uplift of over $150M annually. Led a team of four in simulating the financial impact from changed shopping behavior.• Developed and implemented Minimum Item Quantity policy and smart pricing logic for a multinational chemical company, partnering with 30 cross-functional experts to develop, pilot, and launch. Boosted profit by ~$15-20M run-rate EBITDA through a 3–7% price increase on top-selling products, ~10% increase in order sizes, and small order handling fees for ~20% of small orders.

Frankfurt Area, Germany

Beijing City, China

Master Of Business Administration - Mba

Bachelor Of Science (Bsc), Economics, Finance, And Accounting

Bachelor Of Science (B.Sc.), Finance And Accounting, 4.0

semester abroad